Join        Login             Stock Quote

CooperVision Announces FDA Special 510(K) Clearance on Avaira? Toric Contact Lenses

Thursday, April 5, 2012 2:47 PM

PLEASANTON, Calif., April 5, 2012 /PRNewswire/ -- CooperVision, Inc. today announced that the U.S. Food and Drug Administration has granted a Special 510(k) clearance for CooperVision's Avaira® Toric two-week silicone hydrogel contact lenses for astigmatism. Avaira® Toric highlights CooperVision's commitment to provide eye care practitioners with a choice within the two-week modality segment for their patients. CooperVision will re-launch Avaira® Toric with shipments available for select distribution beginning early May 2012.

CooperVision's Avaira® Toric silicone hydrogel contact lenses offer patients a consistently comfortable lens wearing experience. Avaira® Toric contact lenses also have an optimized ballast design for lens stability providing patients with excellent visual acuity. The consistent fit across the power range offers eye care practitioners a great option for a wide range of astigmatic patients.

Avaira® contact lenses are designed with an innate ability to attract and retain moisture within the lens material without the need for surface treatment or wetting agents. This is thanks to AQUAFORM® Comfort Science™ which makes it the only two-week silicone hydrogel toric that is uniquely naturally wettable. This technology provides comfort that patients can rely on day after day throughout the entire wearing cycle.

About CooperVision
CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world's leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges; such as astigmatism, presbyopia, and ocular dryness; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, thereby creating real advantages for customers and wearers. For more information, visit www.coopervision.com.

SOURCE CooperVision

(Source: PR Newswire )
(Source: Quotemedia)


Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.